Showing results (891-900 of 932) with videos related to

Sort By:
Pageof 94
The Journal of Infectious Diseases|April 19, 2008
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccineM J Levin, M N Oxman, J H Zhang, et al.
Circulation. Heart Failure|May 12, 2016
Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or DeathAllison P Levin, Omar Saeed, Joshua Z Willey, et al.
Brain, Behavior, and Immunity|February 19, 2011
Major depressive disorder and immunity to varicella-zoster virus in the elderlyMichael R Irwin, Myron J Levin, Carmen Carrillo, et al.
International Journal of Obesity (2005)|February 21, 2017
Infant adiposity following a randomised controlled trial of a behavioural intervention in obese pregnancyN Patel, K M Godfrey, D Pasupathy, et al.
The Journal of Infectious Diseases|November 1, 2003
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccineMyron J Levin, Jeffrey G Smith, Robin M Kaufhold, et al.
Annals of Internal Medicine|May 5, 2010
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trialMichael S Simberkoff, Robert D Arbeit, Gary R Johnson, et al.
Nature|February 15, 2011
Crystal structure of a potassium ion transporter, TrkHYu Cao, Xiangshu Jin, Hua Huang, et al.
Vaccine|December 14, 2011
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of ageJoost N Vermeulen, Joep M A Lange, Stephen K Tyring, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019Myron J Levin, Andrew Ustianowski, Steven Thomas, et al.
Memorias Do Instituto Oswaldo Cruz|May 26, 2016
Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern ArgentinaLeticia L Niborski, Vanina Grippo, Sonia O Lafón, et al.
Pageof 94